What's new

Withdrawn application: Amyvid, 26/02/2025

Withdrawn application: Amyvid, 26/02/2025

Mar 28, 2025 - 11:52
 0
Withdrawn application: Amyvid, 26/02/2025
Withdrawn application: Amyvid, 26/02/2025
Read More

Tags:

Previous Article

Summary of opinion: Tevimbra, 27/03/2025 Positive

Next Article

Summary of opinion: Bosulif, 27/03/2025 Positive

Related Posts

Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn

Orphan designation: Octreotide acetate Treatment of acr...

Mar 21, 2025  0

Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

EMEA-003301-PIP01-22-M01

EMEA-003301-PIP01-22-M01

Feb 17, 2025  0